{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:56:05Z","timestamp":1790114165058,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T00:00:00Z","timestamp":1546041600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12020-018-01832-6","type":"journal-article","created":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T03:47:45Z","timestamp":1546055265000},"page":"531-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["18F-choline PET\/CT incidental thyroid uptake in patients studied for prostate cancer"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0810-6494","authenticated-orcid":false,"given":"Domenico","family":"Albano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rexhep","family":"Durmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Giubbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,29]]},"reference":[{"key":"1832_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0889-8529(05)70123-7","volume":"29","author":"B Burguera","year":"2000","unstructured":"B. Burguera, H. Gharib, Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol. Metab. Clin. N. Am. 29, 187\u2013203 (2000)","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"1832_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00405-010-1207-1","volume":"267","author":"NG Iyer","year":"2010","unstructured":"N.G. Iyer, A.R. Shaha, C.E. Silver, K.O. Devaney, A. Rinaldo, P.K. Pellitteri et al. Thyroid incidentalomas: to treat or not to treat. Eur. Arch. Otorhinolaryngol. 267, 1019\u20131026 (2010)","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"1832_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s40336-017-0253-8","volume":"5","author":"A Tamburello","year":"2017","unstructured":"A. Tamburello, G. Treglia, D. Albano, F. Bertagna, L. Giovanella, Prevalence and clinical significance of focal incidental 18F-FDG uptake in different organs: an evidence-based summary. Clin. Transl. Imaging 5, 525 (2017)","journal-title":"Clin. Transl. Imaging"},{"key":"1832_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.biopha.2007.05.001","volume":"61","author":"M Salvatori","year":"2007","unstructured":"M. Salvatori, L. Melis, P. Castaldi, M.L. Maussier, V. Rufini, G. Perotti et al. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography. Biomed. Pharmacother. 61, 488\u2013493 (2007)","journal-title":"Biomed. Pharmacother."},{"key":"1832_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/RLU.0b013e318203bb55","volume":"36","author":"HB Wu","year":"2011","unstructured":"H.B. Wu, Q.S. Wang, M.F. Wang, H.S. Li, Utility of 11C-choline imaging as a supplement to F-18 FDG PET imaging for detection of thyroid carcinoma. Clin. Nucl. Med. 36, 91\u201395 (2011)","journal-title":"Clin. Nucl. Med."},{"key":"1832_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/RLU.0b013e31829f59bd","volume":"38","author":"A Eccles","year":"2013","unstructured":"A. Eccles, A. Challapalli, S. Khan, T. Barwick, S. Mangar, Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET\/CT. Clin. Nucl. Med. 38, 755\u2013757 (2013)","journal-title":"Clin. Nucl. Med."},{"key":"1832_CR7","first-page":"340","volume":"32","author":"G Paone","year":"2013","unstructured":"G. Paone, G. Treglia, M. Bongiovanni, T. Roberto, L. Ceriani, L. Giovanella, Incidental detection of Hurtle cell adenoma by 18F-choline PET\/CT scan in a patient with prostate cancer. Rev. Esp. Med Nucl. Imagen Mol. 32, 340\u2013341 (2013)","journal-title":"Rev. Esp. Med Nucl. Imagen Mol."},{"key":"1832_CR8","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1097\/RLU.0b013e3182817d78","volume":"39","author":"G Treglia","year":"2014","unstructured":"G. Treglia, E. Giovannini, P. Mirk, D. Di Franco, L. Oragano, F. Bertagna, A thyroid incidentaloma detected by 18F-choline PET\/CT. Clin. Nucl. Med. 39, e267\u2013e269 (2014)","journal-title":"Clin. Nucl. Med."},{"key":"1832_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2478\/raon-2013-0075","volume":"48","author":"M Hodolic","year":"2014","unstructured":"M. Hodolic, V. Huchet, S. Balogova, L. Michaud, K. Kerrou, V. Nataf et al. Incidental uptake of 18F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer. Radiol. Oncol. 48, 228\u2013234 (2014)","journal-title":"Radiol. Oncol."},{"key":"1832_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2967\/jnmt.114.145433","volume":"43","author":"AL Aziz","year":"2015","unstructured":"A.L. Aziz, F. Courbon, L.O. Diericks, P. Pascal, S. Zerdoud, Oncocytic adenoma of thyroid incidentally detected by 18F-fluorocholine PET\/CT. J. Nucl. Med. Technol. 43, 133\u2013134 (2015)","journal-title":"J. Nucl. Med. Technol."},{"key":"1832_CR11","first-page":"37","volume":"32","author":"AM Garcia Vicente","year":"2013","unstructured":"A.M. Garcia Vicente, A. Nunez Garcia, A.M. Soriano Castrejon, G.A. Jimenez Londono, J.M. Cordero Garcia, A. Palomar Munoz, Pitfalls with 18F-choline PET\/CT in patients with prostate cancer. Rev. Esp. Med Nucl. Imagen Mol. 32, 37\u201339 (2013)","journal-title":"Rev. Esp. Med Nucl. Imagen Mol."},{"key":"1832_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/RLU.0000000000001181","volume":"41","author":"P Lalire","year":"2016","unstructured":"P. Lalire, M. Zalzali, C. Garbar, C. Bruna-Muraille, D. Morland, Incidental detection of oxifilic papillary thyroid carcinoma by 18F-fluorocholine PET\/CT. Clin. Nucl. Med. 41, 512\u2013513 (2016)","journal-title":"Clin. Nucl. Med."},{"key":"1832_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000447184","volume":"10","author":"A Outtara","year":"2016","unstructured":"A. Outtara, T. Ribeiro de Oliveira, S. Holz, H. Van den Bossche, D. Strybol, C. Assenmacher et al. Incidental detection of occult thyroid carcinoma with 11C-choline PET\/CT for high risk prostate cancer. Curr. Urol. 10, 217\u2013220 (2016)","journal-title":"Curr. Urol."},{"key":"1832_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s13139-017-0488-3","volume":"52","author":"NTK Thanseer","year":"2018","unstructured":"N.T.K. Thanseer, S.K. Bhadada, A. Sood, A.S. Parihar, D. Dahiya, P. Singh et al. Dual pathologies of parathyroid adenoma and papillary thyroid cancer on fluorocholine and fluorodeoxyglucose PET\/CT. Nucl. Med. Mol. Imaging 52, 154\u2013158 (2018)","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"1832_CR15","doi-asserted-by":"publisher","unstructured":"R. Ciappuccini, C. Jeanne, S. Bardet, Incidental focal thyroid uptake on 18F-choline PET\/CT: need to rule out thyroid cancer. Endocrine (2018). \n                    https:\/\/doi.org\/10.1007\/s12020-018-1705-2","DOI":"10.1007\/s12020-018-1705-2"},{"key":"1832_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cpet.2014.03.001","volume":"9","author":"M Beheshti","year":"2014","unstructured":"M. Beheshti, A. Haroon, J.B. Bomanji, W. Langsteger, Fluorocholine PET\/computed tomography. Physiologic uptake, bening findings, and pitfalls. Pet. Clin. 9, 299\u2013306 (2014)","journal-title":"Pet. Clin."},{"key":"1832_CR17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/MNM.0000000000000372","volume":"36","author":"A Haroon","year":"2015","unstructured":"A. Haroon, L. Zanoni, M. Celli, R. Zakavi, M. Beheshti, W. Langsteger et al. Multicenter study evaluating extraprostatic uptake of 11C-choline, 18F-methylcholine, and 18F-ethylcholine in male patients: physiological distribution, statistical differences, imaging pearls, and normal variants. Nucl. Med Comm. 36, 1065\u20131075 (2015)","journal-title":"Nucl. Med Comm."},{"key":"1832_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/BF02984484","volume":"18","author":"N Khan","year":"2004","unstructured":"N. Khan, N. Oriuchi, H. Ninomiya, T. Higuchi, H. Kamada, K. Endo, Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET. Ann. Nucl. Med. 18, 409\u2013417 (2004)","journal-title":"Ann. Nucl. Med."},{"key":"1832_CR19","first-page":"1051","volume":"44","author":"T Torizuka","year":"2003","unstructured":"T. Torizuka, T. Kanno, M. Futatsubashi, H. Okada, E. Yoshikawa, F. Nakamura et al. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. J. Nucl. Med. 44, 1051\u20131056 (2003)","journal-title":"J. Nucl. Med."},{"key":"1832_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00004728-200303000-00013","volume":"27","author":"T Yanagawa","year":"2003","unstructured":"T. Yanagawa, H. Watanabe, T. Inoue, A.R. Ahmed, K. Tomiyoshi, T. Shinozaki et al. Carbon-11 choline positron emission tomography in musculoskeletal tumours: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography. J. Comput. Assist. Tomogr. 27, 175\u2013182 (2003)","journal-title":"J. Comput. Assist. Tomogr."},{"key":"1832_CR21","doi-asserted-by":"publisher","unstructured":"A. Piccardo, P. Trimboli, M. Rutigliani, M. Puntoni, L. Foppiani, L. Bacigalupo et al. Additional value of integrated 18F-choline PET\/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile. Eur J Nucl Med Mol Imaging (2018). \n                    https:\/\/doi.org\/10.1007\/s00259-018-4147-4","DOI":"10.1007\/s00259-018-4147-4"},{"key":"1832_CR22","doi-asserted-by":"publisher","unstructured":"Y. Nakanishi, K. Kitajima, Y. Yamada, T. Hashimoto, T. Suzuki, S. Go et al. Diagnostic performance of 11C-choline PET\/CT and FDG PET\/CT for staging and restaging of renal cell cancer. Ann Nucl Med. (2018). \n                    https:\/\/doi.org\/10.1007\/s12149-018-1287-3","DOI":"10.1007\/s12149-018-1287-3"},{"key":"1832_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1148\/rg.2016150135","volume":"36","author":"C Welle","year":"2016","unstructured":"C. Welle, E.L. Cullen, P.J. Peller, V.J. Lowe, R.C. Murphy, G.B. Johnson et al. 11C-choline PET\/CT in recurrent prostate cancer and nonprostatic neoplastic processes. Radiographics 36, 279\u2013292 (2016)","journal-title":"Radiographics"},{"key":"1832_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/MNM.0b013e328330adc5","volume":"31","author":"O Schillaci","year":"2010","unstructured":"O. Schillaci, F. Calabria, M. Tavolozza, C. Cicci\u00f2, M. Carlani, C.R. Caracciolo et al. 18F-choline PET\/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer. Nucl. Med. Commun. 31, 39\u201345 (2010)","journal-title":"Nucl. Med. Commun."},{"key":"1832_CR25","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1097\/RLU.0000000000000858","volume":"40","author":"A Piccardo","year":"2015","unstructured":"A. Piccardo, M. Massollo, R. Bandelloni, A. Arlandini, L. Foppiani, Lymph node metastasis from tall-cell thyroid cancer negative on 18F-FDG PET\/CT and detected by 18F-choline PET\/CT. Clin. Nucl. Med. 40, e417\u2013e419 (2015)","journal-title":"Clin. Nucl. Med."},{"key":"1832_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.beem.2011.06.004","volume":"26","author":"J Jin","year":"2012","unstructured":"J. Jin, C.R. McHenry, Thyroid incidentaloma. Best. Pract. Res. Clin. Endocrinol. Metab. 26, 83\u201396 (2012)","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"1832_CR27","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1210\/jc.2012-2390","volume":"97","author":"F Bertagna","year":"2012","unstructured":"F. Bertagna, G. Treglia, A. Piccardo, R. Giubbini, Diagnostic and clinical significance of F-18-FDG-PET\/CT thyroid incidentalomas. J. Clin. Endocrinol. Metab. 97, 3866\u20133875 (2012)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-01832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-01832-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-01832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T19:06:31Z","timestamp":1577559991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-01832-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,29]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-01832-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,29]]},"assertion":[{"value":"24 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}